Current Appointments & Affiliations
Associate Professor of Surgery
·
2025 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Recent Publications
Acute kidney injury following radical nephrectomy and inferior vena cava thrombectomy: A tertiary referral center experience.
Journal Article Urol Oncol · February 20, 2026 PURPOSE: To investigate the incidence and determine the risk factors associated with acute kidney injury (AKI) following radical nephrectomy with inferior vena cava (IVC) thrombectomy. METHODS: We retrospectively reviewed the records of patients who underw ... Full text Link to item CiteDoes Cardiopulmonary Bypass Affect Outcomes in Nephrectomy with Level III/IV Caval Thrombectomy for Renal Cell Carcinoma?
Journal Article Curr Oncol · November 29, 2025 Radical nephrectomy with inferior vena cava (IVC) thrombectomy is a technically complex procedure. Cardiopulmonary bypass (CPB) is frequently employed for managing high-level thrombi, yet its impact on surgical outcomes remains uncertain. This study evalua ... Full text Link to item CiteAcellular Tissue Engineered Vessels as Coronary Artery Bypass Grafts.
Journal Article JACC Basic Transl Sci · October 2025 Coronary artery bypass graft (CABG) uses the patient's internal mammary artery and saphenous vein; however, unavailable or poor quality autologous vessels limit revascularization. This study addresses the critical need for alternative CABG conduits by eval ... Full text Link to item CiteRecent Grants
Epicardial Delivery of XC001 Gene therapy to promote Angiogenesis in CAD Patients undergoing Treatment with CABG (The EXACT-CABG Trial)
Clinical TrialPrincipal Investigator · Awarded by XyloCor Therapeutics · 2025 - 2033Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety
Clinical TrialPrincipal Investigator · Awarded by XyloCor Therapeutics · 2025 - 2033Protocol Title: Pulse Biosciences' CellFX® nanosecond Pulsed Field Ablation (nsPFA)¿ Cardiac Surgery Clamp System for treatment of Atrial Fibrillation (AF) during concomitant cardiac surgery PRO00119255
Clinical TrialPrincipal Investigator · Awarded by Pulse Biosciences, Inc. · 2026 - 2031View All Grants
Education, Training & Certifications
University of Miami, Leonard M. Miller School of Medicine ·
2007
M.D.
Vanderbilt University ·
2001
B.S.